Trabectedin and low-dose radiation therapy in patients with advanced leiomyosarcoma.

Javier Martín-BrotoAlicia Olarte-GarcíaRicardo Fernandéz-RodríguezMarta Ribeiro FerreiraIrene Carrasco-GarcíaFernando Galvez-MontosaInmaculada Rincon-PerezJavier Peinado-SerranoIgnacio AzinovicLaura Guzman-GomezLurdes SalgadoAlberto SevillanoJusto OrtegaCristina AlvarezAntonio GutierrezDavid S MouraNadia Hindi

Published in: Therapeutic advances in medical oncology (2024)

Even when extraordinarily long-lasting responses do exist among leiomyosarcoma patients treated with T-XR, we were unable to demonstrate a significant difference favoring leiomyosarcoma patients in clinical outcomes.

Keyphrases

low dose
radiation therapy
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
high dose
patient reported outcomes
locally advanced
patient reported